BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Business

  Dyax Corp. Announces the Resignation of Thomas Beck, M.D., President and Chief Operating Officer

  May 4, 2007

   · 

  1 min read
• Drug Development

  Argos Therapeutics, Inc. Presents Immunosuppression Data for Soluble CD83 at the American Society of Transplantation Congress 2007

  May 4, 2007

   · 

  1 min read
• BioMidwest

  ATS Medical, Inc. 3f Aortic Bioprosthesis Offers Unique Approach to Enhanced Durability

  May 4, 2007

   · 

  1 min read
• Business

  CELLECTIS SA Grants GlaxoSmithKline a Non-Exclusive Sub-License for its Homologous Recombination Technology

  May 4, 2007

   · 

  1 min read
• BioForest

  Biotechnology Industry Organization (BIO) To Unveil Innovative Polls Comparing Views of Top-Level Biotech Executives, Public on Key Biotech Issues

  May 4, 2007

   · 

  1 min read
• Business

  GTx, Inc. Reports First Quarter 2007 Financial Results

  May 4, 2007

   · 

  1 min read
• Pharm Country

  Merck & Co., Inc. Statement on Brazilian Government’s Decision To Issue Compulsory License for STOCRIN(TM)

  May 4, 2007

   · 

  1 min read
• Drug Development

  KAI Pharmaceuticals, Inc. Initiates Phase 1 Trial of KAI-1455 for Ischemic Injury

  May 4, 2007

   · 

  1 min read
• Drug Development

  Teva Neuroscience, Inc.'s COPAXONE(R) Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients

  May 4, 2007

   · 

  1 min read
• Drug Development

  Treatment with Teva Neuroscience, Inc.'s COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis

  May 4, 2007

   · 

  1 min read